Black Diamond Therapeutics

$34.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.98 (+2.93%) Today

$0.00 (0.00%) As of 1:07 PM EST after-hours

Why Robinhood?

You can buy or sell BDTX and other stocks, options, and ETFs commission-free!

About BDTX

Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA. The listed name for BDTX is Black Diamond Therapeutics, Inc. Common Stock.

CEO

David M. Epstein

Employees

Headquarters

Cambridge, Massachusetts

Founded

2014

Market Cap

1.24B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

267.03K

High Today

$34.92

Low Today

$33.50

Open Price

$33.50

Volume

109.31K

52 Week High

$46.25

52 Week Low

$17.63

Collections

BDTX Earnings

-$4.63

-$3.09

-$1.54

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 23, Pre-Market